Hematology & Oncology Doctors in Warren, MI Accepting Medicare

7 Hematology & Oncology doctors found. Showing 1 - 7

Dr. Martin Irvin Schock, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11885 E 12 Mile Rd, Suite 100a, Warren, MI 48093 Phone: 586-576-1615    Fax: 586-576-1628

Ms. Himaja Gaddipati, DO Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 11800 E 12 Mile Rd, Warren, MI 48093 Phone: 719-351-9547

Elon Knoll, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11885 E 12 Mile Rd Ste 100a, Warren, MI 48093 Phone: 586-576-1615    Fax: 586-576-1629

Kenneth Tucker, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11900 E 12 Mile Rd, Suite 300, Warren, MI 48093 Phone: 586-751-2072    Fax: 586-751-1302

Allen N Stawis, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 11900 E 12 Mile Rd, Suite 300, Warren, MI 48093 Phone: 586-751-2072    Fax: 586-751-1302

Dr. Efstathios S Tapazoglou, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 11900 E 12 Mile Rd, Suite 210, Warren, MI 48093 Phone: 586-558-4700    Fax: 586-558-4706

Dr. Vijayalakshmi Donthireddy, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Macomb Hematology Oncology, 11900 East 12mile Suite 210, Warren, MI 48093 Phone: 586-558-4700    Fax: 586-558-4706

News Archive

Fujirebio Diagnostics receives FDA 510(k) clearance for Risk of Ovarian Malignancy Algorithm test

Fujirebio Diagnostics, the industry leader in oncology biomarker assays, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company's HE4 Test in an algorithm called ROMA (HE4 EIA + ARCHITECT CA 125 II) to aid in assessing whether a premenopausal or postmenopausal woman who presents with an ovarian adnexal mass is at high or low likelihood of finding malignancy on surgery.

'Traffic light' food labels associated with reduction in calories purchased by hospital employees

A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.

New study reveals that perception of color depends on biological processes of the eye and brain

Color is normally thought of as a fundamental attribute of an object: a red Corvette, a blue lake, a pink flamingo. Yet despite this popular notion, new research suggests that our perception of color is malleable, and relies heavily on biological processes of the eye and brain.

MHQP reports significant differences in quality of care delivered by Massachusetts medical groups

Massachusetts Health Quality Partners announced today that despite improvement, there are significant differences in the quality of care delivered by medical groups in Massachusetts, according to its annual Quality Insights: Clinical Quality in Primary Care report.

What is the frequency of COVID testing to prevent Delta variant transmission?

In a new study published on the medRxiv* preprint server, scientists have used available data on the Delta variant's viral load to infer its infectiousness and, subsequently, estimate the reduction in its transmission brought about by surveillance testing. The testing, done at different frequencies, was performed on a susceptible population. The cases of both the original Wuhan strain and the Delta variant were considered.

Read more Medical News

› Verified 1 days ago